本頁面由Tiger Trade Technology Pte. Ltd.提供服務

BioCryst製藥

8.54
-0.1650-1.90%
成交量:265.63萬
成交額:2,299.60萬
市值:21.81億
市盈率:-5.67
高:8.84
開:8.60
低:8.49
收:8.70
52周最高:11.22
52周最低:6.00
股本:2.56億
流通股本:2.22億
量比:0.56
換手率:1.20%
股息:- -
股息率:- -
每股收益(TTM):-1.5054
每股收益(LYR):1.21
淨資產收益率:587.33%
總資產收益率:52.86%
市淨率:-4.80
市盈率(LYR):7.05

資料載入中...

2020/02/25

重要事件披露

Current report, items 5.02 and 9.01
2020/02/18

重要事件披露

Current report, items 8.01 and 9.01
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/14

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/05

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/03

重要事件披露

Current report, items 8.01 and 9.01
2020/01/22

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/15

重要事件披露

Current report, items 8.01 and 9.01
2020/01/13

重要事件披露

Current report, items 5.02, 7.01, and 9.01
2019/12/11

重要事件披露

Current report, items 8.01 and 9.01
2019/11/21

重要事件披露

Current report, items 1.01 and 9.01
2019/11/20

重要事件披露

Current report, items 1.01 and 9.01
2019/11/19

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/11/18

重要事件披露

Current report, items 8.01 and 9.01
2019/11/08

季度報告

Quarterly report [Sections 13 or 15(d)]